(Q43965311)

28 November 2017

title

Larger temporal volume in elderly with high versus low beta-amyloid deposition (English)

1 reference

28 November 2017

3

1 reference

28 November 2017

5

1 reference

28 November 2017

6

1 reference

28 November 2017

7

1 reference

28 November 2017

10

1 reference

28 November 2017

Olivier Salvado

9

0 references

Jean-Claude Baron

Jean-Claude Baron

4

0 references

Kathryn A Ellis

Kathryn A Ellis

8

0 references

Ralph Martins

Ralph N Martins

11

0 references

Colin L. Masters

13

Colin L Masters

1 reference

28 November 2017

Gaël Chételat

1

1 reference

28 November 2017

Victor L Villemagne

2

1 reference

28 November 2017

David Ames

12

1 reference

28 November 2017

Christopher C Rowe

14

1 reference

28 November 2017

Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) Research Group

15

1 reference

28 November 2017

language of work or name

English

0 references

publication date

25 August 2010

1 reference

28 November 2017

1 reference

28 November 2017

volume

133

1 reference

28 November 2017

issue

11

1 reference

28 November 2017

page(s)

3349-3358

1 reference

Subjective Memory Impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Voxel-based morphometry–the methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Education modifies the relation of AD pathology to level of cognitive function in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Factors associated with resistance to dementia despite high Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Selective increase of cortical thickness in high-performing elderly--structural indices of optimal cognitive aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

A voxel-based morphometric study of ageing in 465 normal adult human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Development of dementing illnesses in an 80-year-old volunteer cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Microglial activation and amyloid deposition in mild cognitive impairment: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Mild cognitive impairment as a clinical entity and treatment target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

"Preclinical" AD revisited: neuropathology of cognitively normal older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Cognitive reserve and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Vitamin B12 status and rate of brain volume loss in community-dwelling elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ187

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWQ187

1 reference

28 November 2017

1 reference